<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0"><channel><title>Yahoo! Finance: THLD News</title><copyright>Copyright (c) 2009 Yahoo! Inc. All rights reserved.</copyright><link>http://finance.yahoo.com/q/h?s=thld</link><description>Latest Financial News for Threshold Pharmaceuticals, Inc.</description><language>en-us</language><lastBuildDate>Mon, 7 Dec 2009 21:00:00 Etc/GMT</lastBuildDate><image><url>http://us.news2.yimg.com/us.yimg.com/p/fi/pr/40197.gif</url><title>Yahoo! Finance</title><link>http://finance.yahoo.com</link><width>144</width><height>17</height></image><item><title>Threshold Pharmaceuticals Announces Preclinical Multiple Myeloma Data (GlobeNewswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091207/179830.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/1782062131</guid><pubDate>Mon, 7 Dec 2009 21:00:00 Etc/GMT</pubDate></item><item><title>THRESHOLD PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091120/thld8-k.html</link><description></description><guid isPermaLink="false">yahoo_finance/1821733847</guid><pubDate>Fri, 20 Nov 2009 21:23:17 Etc/GMT</pubDate></item><item><title>THRESHOLD PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091118/thld8-k.html</link><description></description><guid isPermaLink="false">yahoo_finance/3208048920</guid><pubDate>Wed, 18 Nov 2009 21:24:41 Etc/GMT</pubDate></item><item><title>Threshold Pharmaceuticals Presents Interim Prostate Cancer Data From Early Stage Trials of TH-302 (GlobeNewswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091118/178681.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/3476470415</guid><pubDate>Wed, 18 Nov 2009 13:45:00 Etc/GMT</pubDate></item><item><title>Threshold to Present at Lazard Capital Markets Healthcare Conference (GlobeNewswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091116/178461.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/1810846193</guid><pubDate>Mon, 16 Nov 2009 13:25:00 Etc/GMT</pubDate></item><item><title>Threshold Pharmaceuticals Announces Clinical Development Results for Cancer Candidate TH-302 (GlobeNewswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091112/178318.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/1827710970</guid><pubDate>Thu, 12 Nov 2009 21:00:00 Etc/GMT</pubDate></item><item><title>THRESHOLD PHARMACEUTICALS INC Financials (EDGAR Online Financials)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/q/is?s=thld</link><description></description><guid isPermaLink="false">yahoo_finance/3616434216</guid><pubDate>Wed, 11 Nov 2009 14:05:15 Etc/GMT</pubDate></item><item><title>THRESHOLD PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091109/thld8-k.html</link><description></description><guid isPermaLink="false">yahoo_finance/3884033914</guid><pubDate>Mon, 9 Nov 2009 21:26:16 Etc/GMT</pubDate></item><item><title>New Star Analyst Rankings for Threshold Pharmaceuticals, Inc. (StarMine)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/a/r/t/thld.html</link><description></description><guid isPermaLink="false">yahoo_finance/3306203593</guid><pubDate>Sun, 8 Nov 2009 14:19:47 Etc/GMT</pubDate></item><item><title>Threshold Pharmaceuticals 3Q loss widens on costs (AP)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/091106/us_earns_threshold_pharmaceuticals.html?.v=2</link><description>Threshold Pharmaceuticals Inc., a development-stage biotechnology company, said late Thursday its third-quarter loss widened on higher research, development, and interest expenses.</description><guid isPermaLink="false">yahoo_finance/3782071874</guid><pubDate>Fri, 6 Nov 2009 15:43:53 Etc/GMT</pubDate></item><item><title>Threshold Pharmaceuticals Presents Interim Data From a Phase 1/2 Clinical Trial of TH-302 at Sarcoma Meeting (GlobeNewswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091106/177778.html?.v=1</link><description>REDWOOD CITY, Calif. -- Threshold Pharmaceuticals, Inc. today announced clinical trial results related to Threshold&apos;s clinical stage hypoxia-activated prodrug, TH-302. The results were presented at the 15th Annual Connective Tissue Oncology Society Meeting taking place in Miami Beach, Florida from November 5 to 7, 2009.</description><guid isPermaLink="false">yahoo_finance/2628649952</guid><pubDate>Fri, 6 Nov 2009 13:45:00 Etc/GMT</pubDate></item><item><title>THRESHOLD PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091105/thld10-q.html</link><description></description><guid isPermaLink="false">yahoo_finance/3120135315</guid><pubDate>Thu, 5 Nov 2009 21:55:17 Etc/GMT</pubDate></item><item><title>Threshold Pharmaceuticals Reports Third Quarter 2009 Financial Results (GlobeNewswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091105/177710.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/18695559</guid><pubDate>Thu, 5 Nov 2009 21:00:00 Etc/GMT</pubDate></item><item><title>Q3 2009 Threshold Pharmaceuticals, Inc. Earnings Release - Time Not Supplied (CCBN)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/research/earncal/20091105.html?t=thld</link><description></description><guid isPermaLink="false">yahoo_finance/1581025468</guid><pubDate>Thu, 5 Nov 2009 12:07:19 Etc/GMT</pubDate></item><item><title>THRESHOLD PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091019/thld8-k.html</link><description></description><guid isPermaLink="false">yahoo_finance/1113657316</guid><pubDate>Mon, 19 Oct 2009 20:16:50 Etc/GMT</pubDate></item><item><title>Threshold licenses cancer drug to Eleison (AP)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/091015/us_threshold_eleison_licensing_deal.html?.v=1</link><description>Threshold Pharmaceuticals Inc. will license its pancreatic cancer drug candidate glufosfamide to Eleison Pharmaceuticals Inc., the companies said Thursday.</description><guid isPermaLink="false">yahoo_finance/3254909231</guid><pubDate>Thu, 15 Oct 2009 14:41:35 Etc/GMT</pubDate></item><item><title>Early Movers: Pump Up the Volume (at TheStreet.com)</title><link>http://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=12p7jksjn/*http%3A//www.thestreet.com/_yahoo/story/10611942/1/early-movers-pump-up-the-volume.html?cm_ven=YAHOO&amp;cm_cat=FREE&amp;cm_ite=NA</link><description></description><guid isPermaLink="false">yahoo_finance/937829424</guid><pubDate>Thu, 15 Oct 2009 13:36:54 Etc/GMT</pubDate></item><item><title>Threshold Pharmaceuticals Licenses Glufosfamide to Eleison Pharmaceuticals (GlobeNewswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091015/175553.html?.v=1</link><description>REDWOOD CITY, Calif. and PRINCETON, N.J. -- Threshold Pharmaceuticals, Inc. , and Eleison Pharmaceuticals, Inc., today announced the execution of a licensing agreement granting Eleison Pharmaceuticals exclusive worldwide rights to glufosfamide.</description><guid isPermaLink="false">yahoo_finance/2810202286</guid><pubDate>Thu, 15 Oct 2009 12:30:00 Etc/GMT</pubDate></item><item><title>THRESHOLD PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091009/thld8-k.html</link><description></description><guid isPermaLink="false">yahoo_finance/1528630973</guid><pubDate>Fri, 9 Oct 2009 20:30:50 Etc/GMT</pubDate></item><item><title>Movers roundup: Callaway Golf, Supervalu (AP)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/091009/us_movers_roundup_callaway_golf.html?.v=1</link><description>Even though demand is still soft, Callaway Golf Co.&apos;s new products are spurring interest and getting people into its stores, an analyst said Friday.</description><guid isPermaLink="false">yahoo_finance/1002007907</guid><pubDate>Fri, 9 Oct 2009 18:32:48 Etc/GMT</pubDate></item></channel></rss><!-- c6.finance.sp2.yahoo.com compressed/chunked Wed Dec 30 22:50:17 PST 2009 -->
